Ausgabe 6/2018
Inhalt (22 Artikel)
Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!
Poul Flemming Høilund-Carlsen, Søren Hess, Thomas J. Werner, Abass Alavi
Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment
Gary J. R. Cook, Gurdip K. Azad, Benjamin P. Taylor, Eugene Lee, Matthew S. Morrison, Simon Hughes, Stephen Morris, Sarah Rudman, Simon Chowdhury, Vicky Goh
68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer
Christos Sachpekidis, P. Bäumer, K. Kopka, B. A. Hadaschik, M. Hohenfellner, A. Kopp-Schneider, U. Haberkorn, A. Dimitrakopoulou-Strauss
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
Thorsten Derlin, Sebastian Schmuck, Cathleen Juhl, Johanna Zörgiebel, Sophie M. Schneefeld, Almut C. A. Walte, Katja Hueper, Christoph A. von Klot, Christoph Henkenberens, Hans Christiansen, James T. Thackeray, Tobias L. Ross, Frank M. Bengel
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index
Silvia Nicolini, Stefano Severi, Annarita Ianniello, Maddalena Sansovini, Alice Ambrosetti, Alberto Bongiovanni, Emanuela Scarpi, Francesca Di Mauro, Alice Rossi, Federica Matteucci, Giovanni Paganelli
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
Marius E. Mayerhoefer, Markus Raderer, Ulrich Jaeger, Philipp Staber, Barbara Kiesewetter, Daniela Senn, Ferdia A. Gallagher, Kevin Brindle, Edit Porpaczy, Michael Weber, Dominik Berzaczy, Ingrid Simonitsch-Klupp, Christian Sillaber, Cathrin Skrabs, Alexander Haug
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
Thibault Salomon, Catherine Nganoa, Anne-Claire Gac, Christophe Fruchart, Gandhi Damaj, Nicolas Aide, Charline Lasnon
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis
G. M. Kramer, Y. Liu, A. J. de Langen, E. P. Jansma, I. Trigonis, M.-C. Asselin, A. Jackson, L. Kenny, E. O. Aboagye, O. S. Hoekstra, R. Boellaard
The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link?
Giampiero Giovacchini, Andrea Ciarmiello, Elisabetta Giovannini, Andrei Fodor, Cesare Cozzarini, Paola Mapelli, Elena Incerti, Nadia Di Muzio, Luigi Gianolli, Maria Picchio
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
Ulrike Garske-Román, Mattias Sandström, Katarzyna Fröss Baron, Lars Lundin, Per Hellman, Staffan Welin, Silvia Johansson, Tanweera Khan, Hans Lundqvist, Barbro Eriksson, Anders Sundin, Dan Granberg
Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent
Donika Plyku, Esther Mena, Steven P. Rowe, Martin A. Lodge, Zsolt Szabo, Steve Y. Cho, Martin G. Pomper, George Sgouros, Robert F. Hobbs
Antitumor effects of radionuclide treatment using α-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model
Yasuhiro Ohshima, Hitomi Sudo, Shigeki Watanabe, Kotaro Nagatsu, Atsushi B. Tsuji, Tetsuya Sakashita, Yoichi M. Ito, Keiichiro Yoshinaga, Tatsuya Higashi, Noriko S. Ishioka
11C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas
Jun Hatazawa
The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma
Soyoung Kim, Dongwoo Kim, Se Hoon Kim, Mi-ae Park, Jong Hee Chang, Mijin Yun
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Ah Yeon Park, Sara Mohades, Andrea L. Benedet, Min Su Kang, Gassan Massarweh, Jean-Paul Soucy, Serge Gauthier, Pedro Rosa-Neto
Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI
N. A. da Silva, P. Lohmann, J. Fairney, A. W. Magill, A.-M. Oros Peusquens, C.-H. Choi, R. Stirnberg, G. Stoffels, N. Galldiks, X. Golay, K.-J. Langen, N. Jon Shah
A first-in-man PET study of [18F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5
Geoffrey Warnock, Michael Sommerauer, Linjing Mu, Gloria Pla Gonzalez, Susanne Geistlich, Valerie Treyer, Roger Schibli, Alfred Buck, Stefanie D. Krämer, Simon M. Ametamey
Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images
Francisco P. M. Oliveira, Diogo Borges Faria, Durval C. Costa, Miguel Castelo-Branco, João Manuel R. S. Tavares
FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance
Nils Helsen, Tim Van den Wyngaert, Laurens Carp, Sigrid Stroobants
Is it time to change our vision of tumor metabolism prior to immunotherapy?
Fabio Grizzi, Angelo Castello, Egesta Lopci
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion
Kambiz Rahbar, Matthias Weckesser, Hojjat Ahmadzadehfar, Michael Schäfers, Lars Stegger, Martin Bögemann
Correction to: Biological tumour volumes of gliomas in early and standard 20–40 min 18F-FET PET images differ according to IDH mutation status
M. Unterrainer, I. Winkelmann, B. Suchorska, A. Giese, V. Wenter, F. W. Kreth, J. Herms, P. Bartenstein, J. C. Tonn, N. L. Albert